Navigation Links
CardioPharma Prepares for FDA Submission
Date:10/8/2009

mpliance." Dr. Daniel Gregory, CardioPharma's COO, added, "CardiaPill is a product which is less expensive for everyone - fewer co-pays, one dispensing fee, less paperwork and ultimately reduced hospitalization."

CardioPharma, while ahead in the US polypill race, is not alone in the competition to put a cardiovascular polypill into the market place. In Asia, Cipla and Dr. Reddy's have been trying for years and in Spain a group working with Ferrer Laboratories discussed clinical trials in Latin America in 2008. Since Wald and Law in the UK first noted the need for such products, researchers around the world have sought without success to develop a practical polypill.

The CardioPharma team accepted the global polypill development challenge several years ago and is the only group in the race that has the advantage of two issued Harvard patents. CardioPharma also has the advantage of working with a distinguished product development team which includes one of the patent authors. CardioPharma judiciously collected data on thousands of patients and built a regulatory strategy with the guidance of the FDA to enable the product to be registered first in the US and then to be registered and distributed globally.

According to Mr. Sellers, who has over 35-years experience in pharmaceutical management, "The road to success is challenging. We all can recognize the need for a combination drug that data now suggests can reduce cardiovascular events by more than 60%, but we also had to make CardiaPill profitable." CardioPharma continues to persevere, recognizing that even a small percentage of the two $20 Billion+ cardiovascular markets in the US and EU is enticing. Notes Mr. Sellers, "CardiaPill is positioned to be a better economic and medicinal choice for all concerned compared to buying the three individual component medicines. We are not building an expensive product, but rather a single, daily dose pill containing a group of gold stand
'/>"/>

SOURCE CardioPharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
2. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
3. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
4. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
5. Labopharm files New Drug Submission with Health Canada for novel antidepressant
6. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
7. FDA Submission of B-R-A-H-M-S MR-proANP Kryptor
8. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
9. MannKind Updates Status of NDA Submission for AFRESA
10. Kensey Nash Announces IDE Submission for Cartilage Repair Device
11. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Ariz. , July 10, 2014   Ventana ...  Group, today announced it has entered into an agreement ... which operates as EMD Serono in the ... , to collaborate with Merck KGaA,s biopharmaceutical division on ... for an undisclosed target using Ventana,s proprietary diagnostic assays. ...
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... 2014 AARP Foundation today announced it has established a ... the severe cold weather that has gripped much of the ... in need; so to support these emergency relief efforts AARP ... which could mean up to $500,000 in aid. The matching ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
(Date:7/12/2014)... The report, "Phthalic Anhydride and Derivatives (Plasticizers, Unsaturated ... Geography – Trends & Forecast to 2018," defines and ... market volume and value. The report also estimates the ... of phthalic anhydride is projected to grow from an ... 2018, with a CAGR of 5.24% from 2013 to ...
(Date:7/12/2014)... Demand Response Management Systems is a crucial peak load ... between energy supply and demand. With the help of ... to increasing pressure on the grid) and replaced by ... appliances and thermostats for load reduction. , DRMS ... with government mandates and benefits for energy efficiency and ...
(Date:7/12/2014)... July 12, 2014 Casinos ... despite rising competition from international and online casinos. Revenue ... over the five years through 2014-15. Greater per capita ... more gaming services. Rises in discretionary income levels have ... money on non-essential items such as casino gambling services. ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Sean Francis, owner of ... out special challenges to his clients. He’s also known for his ... recently found a way to combine the two and is excited ... $2,000 for the Boys and Girls Club. , The funds are ... started on June 23rd. Francis sent out emails and asked his ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 With prom ... dress manufacturer and retailer, is ready to showcase its ... its new collection of evening dresses in its online ... to 67% off) for these elegant gowns. According to ... an end on July 26, 2014. , He ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2
... (HealthDay News) -- An estimated 50 percent to 55 percent ... according to the Society for Vascular Surgery. "More than ... can lead to more serious health problems," Dr. Eva Rzucidlo, ... society news release. "The first line of management for ...
... News) -- Updated vaccines for rotavirus -- once the leading ... appear to increase the risk of potentially deadly side effects, ... taken off the market in 1999 after it was associated ... versions of the vaccine were reintroduced in 2006 and 2008, ...
... 13 (HealthDay News) -- Due to a growing number of ... for Disease Control and Prevention has issued a reminder that ... person. Using insulin pens on more than one person ... as hepatitis viruses and HIV, which causes AIDS, the agency ...
... become an accepted way to simplify a complex array of ... is an independent disease in itself. However, the truth is ... factors at work explaining the symptoms. This is also one ... do not bring the hoped result," says Kari Tikkinen, MD, ...
... , FRIDAY, Jan. 13 (HealthDay News) -- Women with normal ... methotrexate in the first trimester either miscarried or gave birth ... study suggest. An ectopic pregnancy is one where the ... the fetus cannot grow normally and will not survive. The ...
... more routinely digitized to aid interpretation, a software program ... Health System is proving its utility. In a ... Quantization (SIVQ) was able to separate malignancy from background ... type of bladder cancer whose features can vary widely ...
Cached Medicine News:Health News:Recent Rotavirus Vaccines Safe, Study Says 2Health News:CDC Warns Against Sharing Insulin Pens 2Health News:The concept of 'overactive bladder' serves better commercial rather than patient interests 2Health News:Normal Pregnancies May Be Misdiagnosed as Ectopic 2Health News:Software for analyzing digital pathology images proving its usefulness 2Health News:Software for analyzing digital pathology images proving its usefulness 3
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... The new Synchron LXi 725 ... technology with highly accurate immunoassay testing ... sample handling on a single platform. ... are automatically repeated for optimal quality ...
...
...
Medicine Products: